News
Hosted on MSN11mon
Low-dose glucocorticoids in systemic lupus erythematosus: New evidence around use and thresholdsHowever, the threshold in the validated lupus low disease activity state (LLDAS) definition is no more ... with glucocorticoid compared to low-dose maintenance—based on a retrospective analysis ...
In a phase 2 trial of peanut oral immunotherapy (OIT) involving 21 adults, 67% achieved maintenance dose tolerance, with the median tolerated dose increasing 100-fold from 30 mg to 3000 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results